Summary
Islet capillary area was followed daily in mice after treatment with low-dose streptozocin (LDS), in order to elucidate the exact period during which the insular vascular bed undergoes a significant reduction. Forty C57BL6/J mice were diabetized with 5×40 mg streptozocin (STZ)/kg body wt and killed 6, 8, 9, 10, 11, 12, 15 or 18 days after the first STZ injection. Pancreases were sectioned and processed by staining for alkaline phosphatases using a method devised by Gomori. The percentage of the islet parenchymal area occupied by intra-islet capillaries was measured using a Videoplan videoanalyzer. LDS treatment did not significantly alter the islet capillary area up to day 8; the first signs of reduction were seen on days 9 and 10 (islet capillary area at days 9 and 10 respectively was 2.68% and 2.60% of controls). At day 11 a dramatic decrease in islet capillary area was seen (1.38%), which was not accompanied by a similar reduction of the islet parenchymal area. The reduction in islet capillary area continued to progress up to day 15 by which time it had achieved the lowest level (0.72%). On day 18, values remained practically unchanged.
Similar content being viewed by others
References
Barbosa J, Bach FH (1987) Cell mediated autoimmunity in type 1 diabetes. Diabetes Metab Rev 3:981–1004
Beppu H, Maruta K, Kurner T, Kolb H (1987) Diabetogenic action of streptozocin: essential role of membrane permeability. Acta Endocrinol (Copenh) 114:90–95
Gomori GE (1941) The distribution of phosphatase in normal organs and tissues. J Cell Comp Physiol 17:71–84
Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H (1988) Low-dose-streptozocin induced diabetes in mice. Electron microscopy reveals single cell insulitis before diabetes onset. Diabetes 37:21–27
Like AA, Rossini AA (1976) Streptozocin-induced pancreatic insulitis: a new model of diabetes mellitus. Science 193:415–417
Martin S, Kolb-Bachofen V, Kiesel U, Kolb H (1989) Pathogenesis of low-dose streptozocin diabetes in mice: requirement for alpha 1 adrenoceptor activation and vasoactive amine release. Diabetologia 32:359–367
Papaccio G, Esposito V (1992) Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low dose streptozocin treated mice. Virchows Arch [A] 420:5–10
Papaccio G, Mezzogiorno V (1989) Morphological aspects of glucagon and somatostatin islet cells in diabetic bio breeding and low dose streptozocin treated wistar rats. Pancreas 4:289–294
Papaccio G, Chieffi-Baccari G, Mezzogiorno V, Esposito V (1990) Capillary area in early low-dose streptozocin treated mice. Histochemistry 95:19–21
Papaccio G, Linn T, Federlin K, Volkman A, Esposito V, Mezzogiorno V (1991a) Further morphological and biochemical observations on early low dose streptozocin diabetes in mice. Pancreas 6:659–667
Papaccio G, Frascatore S, Esposito V, Pisanti FA (1991b) Early macrophage infiltration in mice treated with low dose streptozocin decreases islet superoxide dismutase levels. Prevention by silica pre-treatment. Acta Anat 142:141–146
Papaccio G, Latronico M, Frascatore S, Pisanti FA (1991c) Superoxide dismutase in low dose streptozocin treated mice. A dynamic time-course study. Int J Pancreas 10:253–260
Sandler S, Jansson L (1985) Vascular permeability of pancreatic islets after administration of streptozocin. Virchows Arch [A] 407:359–367
Svensson AM, Jansson L, Hellerstrom C (1988) The volume and area of the capillaries in the endocrine and exocrine pancreas of the rat. Histochemistry 90:43–46
Weibel ER (1979) Stereological methods, vol I. Academic Press, London
Weide LG, Lacy PE (1991) Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model. Diabetes 40:1157–1162
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papaccio, G., Chieffi-Baccari, G. Alterations of islet microvasculature in mice treated with low-dose streptozocin. Histochemistry 97, 371–374 (1992). https://doi.org/10.1007/BF00270040
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00270040